Pharmafile Logo

Neurodiversity, ADHD and work: Obstacles and opportunities

October 30, 2018 | ADHD, Employment, mental health 

For ADHD awareness month this year our Associate Medical Writer, Alex Teahan, has written a piece surrounding ADHD and employment. He discusses the advantages and disadvantages of ADHD at work, and areas of improvement for employers in supporting those with ADHD.

ADHD (Attention deficit hyperactivity disorder) is a complex neurogenetic disorder, assessed by measurement of behavioural factors such as inattention, impulsivity and hyperactivity. Variation in these factors are a result of structural, functional and neurochemical differences in the brains of those with ADHD as compared with neurotypical people.[1] These traits can lead to problems with ‘executive functions’ – processes in the brain related to attentional control, impulse control, working memory, emotional regulation and more, some or all of which may be impaired in someone with ADHD.[2] These impairments are present from early childhood, and while some people develop coping mechanisms or organise their lives around the way they function so as to reduce their impact, they generally persist through to adulthood, leading to on average worse educational, occupational, economic, social and relationship outcomes,[3] with higher rates of comorbidities such as mood, anxiety and sleep disorders.[4]

Many aspects of employment pose a particular challenge to people with ADHD;
effective performance at work requires good time management, self-organisation, planning, problem solving, consistent concentration, self-motivation and the delay of gratification in the pursuit of longer-term goals and rewards, all of which are actioned through the executive functions that are impaired in people with ADHD.[5] Unsurprisingly, a large amount of research has demonstrated problems with occupational functioning in people with ADHD relative to control groups, including lower levels of employment and lower ranking occupational status, poorer employer-rated job performance, higher dismissal rates, more sickness days per year and more days of reduced quality and quantity of work, among others.[5-7]

- PMLiVE

Dr Russel Barkley, the clinician most cited and credited for his unifying theory of ADHD,[8] proposes recommendations for what employers should be aware of when managing employees with ADHD:[9]

- PMLiVE

 Despite the negative effects of executive dysfunction at work, certain traits related to ADHD may be advantageous in some occupational circumstances. Reduced inhibitory control (which theoretically results in many ADHD executive dysfunctions[8] has been associated with more effective divergent thinking, in terms of increased frequency and originality of ideas compared with more inhibited individuals. Consistent with these findings, adults with ADHD have demonstrated superior divergent thinking to non-ADHD controls for fluency, flexibility and originality of ideas,[10,11] in addition to higher levels of real-world creative achievement and a higher preference for idea generation rather than problem clarification and idea development.[11] This indicates a potential niche for people with ADHD where their propensity for ‘outside the box’ idea generation could be particularly valuable to organisations.

Hyperfocus is another feature of ADHD only recently receiving attention in the research literature, which is a state of heightened, intense focus which may involve feelings of timelessness, failure to attend to the world, ignoring personal needs, difficulty stopping and switching tasks, feeling totally engrossed, and feeling “stuck” on small details.[12] Counter to what the term ADHD implies, this vein of research and the finding that hyperfocus is more common in people with ADHD[12,13] supports the emerging understanding that ADHD involves a maldistribution of attention rather than a deficit. Activities the person with ADHD finds enjoyable may facilitate access to a hyperfocused state similar to deep-flow,[12] where attention is so focused one feels isolated and detached from the environment.[14] Translated into a work context, this suggests people with ADHD may be able to more easily access a state of intense focus in their work if they find it interesting and enjoyable, resulting in high productivity. 

- PMLiVE

A diversity of life experiences, attitudes, ways of thinking and behaving are vital to ensure organisations don’t succumb to the temptation of conformity and stability in their culture and operations – otherwise, they may find it more difficult to effectively react to external pressures and successfully manage change interventions,[15] avoid groupthink and find innovative solutions to organisational problems.[16]   The potential advantages in ADHD, other types of neurodivergence in the workplace[17] and the benefits of a neurodiverse workforce support a model where rather than merely finding reasonable adjustments to help employees with ADHD manage their work, an individualised approach which discovers and harnesses their strengths and interests is important too. When supported in managing their differences and enabled to pursue what they are interested in and skilled at, people with ADHD are more than capable of succeeding, excelling and innovating.                    

If you would like to know more about how we can work with you visit our website www.mednetgroup.net, or contact us directly via phone 0113 386 4415 or email attigo@mail.me.

References

1. Biederman, J. (2005). Attention-deficit/hyperactivity disorder: a selective overview. Biological psychiatry57(11), 1215-1220.

2. Castellanos, F. X., Sonuga-Barke, E. J., Milham, M. P., & Tannock, R. (2006). Characterizing cognition in ADHD: beyond executive dysfunction. Trends in cognitive sciences10(3), 117-123.
3. Klein, R. G., Mannuzza, S., Olazagasti, M. A. R., Roizen, E., Hutchison, J. A., Lashua, E. C., & Castellanos, F. X. (2012). Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Archives of general psychiatry69(12), 1295-1303.
4. Kooij, J. S., Huss, M., Asherson, P., Akehurst, R., Beusterien, K., French, A., … & Hodgkins, P. (2012). Distinguishing comorbidity and successful management of adult ADHD. Journal of attention disorders16(5_suppl), 3S-19S.
5. Barkley, R. A., & Murphy, K. R. (2010). Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Archives of clinical neuropsychology25(3), 157-173.
6. De Graaf, R., Kessler, R. C., Fayyad, J., ten Have, M., Alonso, J., Angermeyer, M., … & Haro, J. M. (2008). The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative. Occupational and environmental medicine.
7. Gjervan, B., Torgersen, T., Nordahl, H. M., & Rasmussen, K. (2012). Functional impairment and occupational outcome in adults with ADHD. Journal of attention disorders16(7), 544-552.
8. Barkley, R. A. (1997). Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychological bulletin121(1), 65.
9. Barkley, R. A. (2013). Recommendations for employers concerning the management of employees with ADHD. The ADHD Report21(2), 6-13.
10. White, H. A., & Shah, P. (2006). Uninhibited imaginations: creativity in adults with attention-deficit/hyperactivity disorder. Personality and Individual Differences40(6), 1121-1131.
11. White, H. A., & Shah, P. (2011). Creative style and achievement in adults with attention-deficit/hyperactivity disorder. Personality and Individual Differences50(5), 673-677.
12. Hupfeld, K. E., Abagis, T. R., & Shah, P. (2018). Living “in the zone”: hyperfocus in adult ADHD. ADHD Attention Deficit and Hyperactivity Disorders, 1-18.
13. Ozel-Kizil, E. T., Kokurcan, A., Aksoy, U. M., Kanat, B. B., Sakarya, D., Bastug, G., … & Oncu, B. (2016). Hyperfocusing as a dimension of adult attention deficit hyperactivity disorder. Research in developmental disabilities59, 351-358.
14. Moneta, G. B. (2012). On the measurement and conceptualization of flow. In Advances in flow research (pp. 23-50). Springer, New York, NY.
15. Cheung-Judge, M. Y., & Holbeche, L. (2015). Organization development: a practitioner’s guide for OD and HR. Kogan Page Publishers.
16. Austin, R. D., & Pisano, G. P. (2017). Neurodiversity as a competitive advantage. Harvard Business Review95, 96-103.
17. Armstrong, T. (2015). The myth of the normal brain: Embracing neurodiversity. AMA journal of ethics17(4), 348.

This content was provided by Mednet Group

Documents for download:

Company Details

 Latest Content from  Mednet Group 

Pharma conference trends and themes in the last two years

We take an in-depth look at the way Pharma conferences have changed in the last two years and how that’s impacted attendance, themes and format.

Hidden Heroes – Mednet Group Charity Walk for Mind

Every year, we get together as a company to take part in a sponsored walk to raise money for Mind, a charity we have close ties with.

Hidden Heroes – Account Manager’s half-marathon for Alzheimer’s Society

As a business, we place tremendous value in community and giving back. That's why we're so proud to share the charitable achievements of our team.

From Multichannel to Omnichannel

Take a look at the movement to omnichannel communication

Design-thinking. Iterating for continuous improvement.

How design can lead improvement within Pharma

Steph’s Story

Associate Medical Writer, Steph talks about her experiences with Generalised Anxiety Disorder and Panic Attacks

Mario’s Story

Senior Designer, Mario talks about struggling with Generalised Anxiety Disorder, Social Anxiety Disorder resulting in mild OCD

Our Work With Mind

In celebration of Mental Health Awareness Week 2023, we're sharing some of our recent work with Mind.

Spotting the Signs of Dementia is the First Step to Diagnosis

As part of our contribution to dementia awareness week, we wanted to help ground people in the terms often used interchangeably to describe dementia.

Hyper-personalisation – The immediate future of pharma is personalised.

What does hyper-personalisation in Pharma look like?